Table 3 Sociodemographic and study details of qualitative and quantitative samples
|  | Participants providing qualitative data (n = 27) | Participants providing quantitative data (n = 125) | ||||
|---|---|---|---|---|---|---|
| Â | Prescribers | Supporters | Prescriber-supporters | Prescribers | Supporters | Prescriber-supporters |
n | 13 | 11 | 3 | 62 | 58 | 5 |
Gender | 5 female (38%) | 10 female (91%) | 3 female (100%) | 22 female (35%) | 55 female (95%) | 3 female (60%) |
Mean n of patients in intervention group at each Practice (range) | 5 (2–10) | 5 (2–8) | 7 (2–10) | 4.3 (− 1–12) | 4.4 (1–12) | 6.2 (2–10) |
Mean n of weeks from randomisation of first participant to time of interview (range) | 29 weeks (17–54) | 27 weeks (20–43) | 20 weeks (16–24) | N/A | ||
Mean duration of interview (range) | 26:14 (14–37 min) | 29:02 (11–62 min) | 43:19 (37–53 min) | N/A | ||
Mean n of recommendations for medication escalation received by prescriber at point of interview (range) | 3 (0–7) | N/A | 3 (1–4) | N/A | ||